AP9528a-ev
|
Abcepta, Inc.
|
CHMP4B [N-term] [RB24088], Rabbit Polyclonal Antibody
|
Human
|
FC, IHC-P, WB
|
|
AP9528a
|
Abcepta, Inc.
|
CHMP4B [N-term] [RB24088], Rabbit Polyclonal Antibody
|
Human
|
FC, IHC-P, WB
|
|
AP8666b-ev
|
Abcepta, Inc.
|
DSC1 [C-term] [RB21405], Rabbit Polyclonal Antibody
|
Human
|
FC, WB
|
|
AP8666b
|
Abcepta, Inc.
|
DSC1 [C-term] [RB21405], Rabbit Polyclonal Antibody
|
Human
|
FC, WB
|
|
AP8102c-ev
|
Abcepta, Inc.
|
TLK2 [Centre] [RB3046], Rabbit Polyclonal Antibody
|
Human, Mouse
|
WB
|
|
AP8102c
|
Abcepta, Inc.
|
TLK2 [Centre] [RB3046], Rabbit Polyclonal Antibody
|
Human, Mouse
|
WB
|
|
ATGP3462-250ug
|
NKMax Bio (ATGen)
|
Iduronate 2-Sulfatase [26-550 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
ATGP3462-50ug
|
NKMax Bio (ATGen)
|
Iduronate 2-Sulfatase [26-550 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
HY-124295-10mg
|
MedChemexpress LLC
|
MPT0E028 [CAS 1338320-94-7]
|
|
Cancer-Kinase/protease
|
|
HY-124295-100mg
|
MedChemexpress LLC
|
MPT0E028 [CAS 1338320-94-7]
|
|
Cancer-Kinase/protease
|
|
HY-124295-25mg
|
MedChemexpress LLC
|
MPT0E028 [CAS 1338320-94-7]
|
|
Cancer-Kinase/protease
|
|
HY-124295-5mg
|
MedChemexpress LLC
|
MPT0E028 [CAS 1338320-94-7]
|
|
Cancer-Kinase/protease
|
|
HY-124295-50mg
|
MedChemexpress LLC
|
MPT0E028 [CAS 1338320-94-7]
|
|
Cancer-Kinase/protease
|
|
HY-103178-5mg
|
MedChemexpress LLC
|
MRE3008F20 [CAS 252979-43-4]
|
|
Cancer-programmed cell death
|
|
HY-100370-10mg
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9]
|
|
Cancer-programmed cell death
|
|
HY-100370-5mg
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9]
|
|
Cancer-programmed cell death
|
|
HY-100370-50mg
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9]
|
|
Cancer-programmed cell death
|
|
HY-100370-1mL
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-103190-10mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
HY-103190-100mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
HY-103190-25mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
HY-103190-5mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
HY-103190-50mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
HY-153356-10mg
|
MedChemexpress LLC
|
MRT-2359 [CAS 2803881-11-8]
|
|
Cancer-programmed cell death
|
|
HY-153356-100mg
|
MedChemexpress LLC
|
MRT-2359 [CAS 2803881-11-8]
|
|
Cancer-programmed cell death
|
|